GSK stock slips to EUR 22.86, down 1.00% premarket
Published on 11/17/2026 at 07:50 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSWhat Shapes GSK Stock Now
- GSK operates across specialty medicines, vaccines and general medicines.
- Patent expiries in the HIV franchise remain a long-term risk for the drugmaker.
- Pipeline investment is central to replacing products that face loss of exclusivity.
GSK stock traded at EUR 22.86 on Lang & Schwarz at 07:48 CET on Tuesday, November 17, 2026, 1.00 percent below the Xetra close of EUR 23.09 on Monday, November 16.
GSK operates across specialty medicines, vaccines and general medicines, according to AJ Bell. Investors continue to weigh pipeline growth against patent expiries in the HIV franchise.
Broader UK equities can be followed in the FTSE 100.
Disclaimer...
en | GB00BN7SWP63 | GSK | boerse | 70525101 | bgmi
